Certuity LLC grew its holdings in shares of Morgan Stanley (NYSE:MS – Free Report) by 0.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 203,121 shares of the financial services provider’s stock after acquiring an additional 652 shares during the quarter. Morgan Stanley accounts for approximately 2.8% of Certuity LLC’s holdings, making the stock its 7th biggest holding. Certuity LLC’s holdings in Morgan Stanley were worth $25,536,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in the business. Franklin Resources Inc. raised its position in shares of Morgan Stanley by 75.2% in the 3rd quarter. Franklin Resources Inc. now owns 7,850,848 shares of the financial services provider’s stock worth $881,493,000 after acquiring an additional 3,369,520 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of Morgan Stanley by 382.4% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,597,800 shares of the financial services provider’s stock worth $166,555,000 after purchasing an additional 1,266,600 shares in the last quarter. International Assets Investment Management LLC bought a new stake in shares of Morgan Stanley in the 4th quarter worth approximately $89,761,000. Fisher Asset Management LLC increased its position in Morgan Stanley by 2.7% during the 3rd quarter. Fisher Asset Management LLC now owns 22,404,981 shares of the financial services provider’s stock valued at $2,335,495,000 after buying an additional 590,872 shares in the last quarter. Finally, Strategic Financial Concepts LLC purchased a new position in Morgan Stanley during the fourth quarter valued at $71,927,000. 84.19% of the stock is currently owned by institutional investors.
Morgan Stanley Stock Performance
Shares of NYSE MS opened at $137.80 on Wednesday. The firm has a market capitalization of $222.00 billion, a price-to-earnings ratio of 17.35, a price-to-earnings-growth ratio of 1.24 and a beta of 1.37. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 3.14. The firm has a 50 day moving average of $130.80 and a 200 day moving average of $117.70. Morgan Stanley has a 12-month low of $83.09 and a 12-month high of $142.03.
Morgan Stanley Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 31st will be issued a dividend of $0.925 per share. This represents a $3.70 annualized dividend and a yield of 2.69%. The ex-dividend date is Friday, January 31st. Morgan Stanley’s dividend payout ratio is currently 46.60%.
Insiders Place Their Bets
In other Morgan Stanley news, insider Eric F. Grossman sold 13,097 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $136.20, for a total value of $1,783,811.40. Following the completion of the transaction, the insider now directly owns 197,444 shares in the company, valued at $26,891,872.80. This represents a 6.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Raja Akram sold 17,500 shares of the stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $136.01, for a total transaction of $2,380,175.00. Following the sale, the chief financial officer now directly owns 81,440 shares of the company’s stock, valued at approximately $11,076,654.40. This trade represents a 17.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.24% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts recently issued reports on the stock. HSBC cut shares of Morgan Stanley from a “buy” rating to a “hold” rating and upped their price target for the stock from $128.00 to $131.00 in a research note on Tuesday, November 26th. Jefferies Financial Group increased their price target on shares of Morgan Stanley from $120.00 to $135.00 and gave the company a “buy” rating in a report on Thursday, October 17th. The Goldman Sachs Group boosted their price objective on shares of Morgan Stanley from $106.00 to $121.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. UBS Group increased their target price on Morgan Stanley from $130.00 to $140.00 and gave the company a “neutral” rating in a research note on Tuesday, January 21st. Finally, Evercore ISI boosted their price target on Morgan Stanley from $140.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 17th. Eleven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $131.27.
Read Our Latest Analysis on Morgan Stanley
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Further Reading
- Five stocks we like better than Morgan Stanley
- How to Use the MarketBeat Stock Screener
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Best Aerospace Stocks Investing
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- The 3 Best Fintech Stocks to Buy Now
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.